AAAAAA
Results:
1-25
|
Results: 25
Authors:
LOKICH J
ANDERSON N
BERN M
COCO F
GOTTHARDT S
OLIYNYK P
DOW E
Citation: J. Lokich et al., PACLITAXEL, CISPLATIN, ETOPOSIDE COMBINATION CHEMOTHERAPY - A MULTIFRACTIONATED BOLUS DOSE SCHEDULE FOR NONSMALL CELL LUNG-CANCER, European journal of cancer, 34(5), 1998, pp. 659-663
Authors:
LOKICH J
ANDERSON N
MOORE C
BERN M
COCO F
SONNEBORN H
DOW E
STRONG D
Citation: J. Lokich et al., PACLITAXEL, CISPLATIN AND ETOPOSIDE COMBINATION CHEMOTHERAPY - A COMPARISON OF DOSE INTENSITY IN 2 MULTIFRACTIONATED DOSE SCHEMAS, European journal of cancer, 34(5), 1998, pp. 664-667
Authors:
LOKICH J
MOORE C
ANDERSON N
BERN M
COCO F
DOW E
ZIPOLI T
Citation: J. Lokich et al., PHASE-I PHASE-II TRIAL OF 14 DAY INFUSIONAL 6-MERCAPTOPURINE IN ADVANCED COLORECTAL-CANCER, European journal of cancer, 34(4), 1998, pp. 584-585
Authors:
LOKICH J
ANDERSON N
Citation: J. Lokich et N. Anderson, PACLITAXEL HYPERSENSITIVITY REACTIONS - A ROLE FOR DOCETAXEL SUBSTITUTION, Annals of oncology, 9(5), 1998, pp. 573-573
Authors:
LOKICH J
BECK T
CHEVLEN E
HOCHSTER H
OROURKE M
WEAVER C
BELL W
MCGUIRT C
LEVIN J
HOHNEKER J
MANI S
Citation: J. Lokich et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 169-169
Authors:
LOKICH J
ANDERSON N
Citation: J. Lokich et N. Anderson, CARBOPLATIN VERSUS CISPLATIN IN SOLID TUMORS - AN ANALYSIS OF THE LITERATURE. (VOL 9, PG 13, 1998), Annals of oncology, 9(3), 1998, pp. 341-341
Authors:
LOKICH J
ANDERSON N
Citation: J. Lokich et N. Anderson, CARBOPLATIN VERSUS CISPLATIN IN SOLID TUMORS - AN ANALYSIS OF THE LITERATURE, Annals of oncology, 9(1), 1998, pp. 13-21
Authors:
LOKICH J
Citation: J. Lokich, INFUSIONAL 5-FU - HISTORICAL EVOLUTION, RATIONALE, AND CLINICAL-EXPERIENCE, Oncology, 12(10), 1998, pp. 19-22
Authors:
LOKICH J
SHERBURNE B
Citation: J. Lokich et B. Sherburne, KI-1 ANAPLASTIC LARGE-CELL LYMPHOMA IN THE DIFFERENTIAL-DIAGNOSIS OF UNKNOWN PRIMARY-CANCER, Cancer investigation, 16(5), 1998, pp. 309-313
IMPROVING 5-FLUOROURACIL - BIOMODULATION, PHARMACOMODULATION, OR INFUSIONAL ADMINISTRATION SCHEDULES
Authors:
LOKICH J
Citation: J. Lokich, IMPROVING 5-FLUOROURACIL - BIOMODULATION, PHARMACOMODULATION, OR INFUSIONAL ADMINISTRATION SCHEDULES, Cancer investigation, 16(4), 1998, pp. 293-294
Authors:
LOKICH J
Citation: J. Lokich, INCURABLE BREAST-CANCER AND LONG-TERM SURVIVAL - ANECDOTES TOWARD A NEW PARADIGM, Cancer investigation, 16(4), 1998, pp. 295-296
Authors:
LEVY E
PIEDBOIS P
BUYSE M
PIGNON JP
ROUGIER P
RYAN L
HANSEN R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
BRUFMAN G
ISACSON R
LAPLANCHE A
QUINAUX E
THIRION P
RYAN L
HANSEN R
HARRINGTON D
MCFADDEN E
RIBBLE A
JACOBSON R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
PIGNON JP
LAPLANCHE A
LUBOINSKI M
ROUGIER P
BRUFMAN G
ISACSON R
VAITKEVICIUS V
PIEDBOIS P
LEBOURGEOIS JP
PIEDBOIS Y
GAUTHIER E
LEVY E
THIRION P
DURANDZALENSKI I
BUYSE M
QUINAUX E
WOLMARK N
PIEDBOIS P
BUYSE M
CARLSON R
RUSTUM Y
ERLICHMAN C
Citation: E. Levy et al., TOXICITY OF FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - EFFECT OF ADMINISTRATION SCHEDULE AND PROGNOSTIC FACTORS, Journal of clinical oncology, 16(11), 1998, pp. 3537-3541
Authors:
WOLMARK N
PIEDBOIS P
ROUGIER P
BUYSE M
PIGNON JP
RYAN L
HANSEN R
ZEE B
WEINERMAN B
PATER J
LEICHMAN C
MACDONALD J
BENEDETTI J
LOKICH J
FRYER J
BRUFMAN G
ISACSON R
LAPLANCHE A
LEVY E
HARRINGTON D
MCFADDEN E
RIBBLE A
JACOBSON R
LUBOINSKI M
VAITKEVICIUS V
LEBOURGEOIS JP
PIEDBOIS Y
GAUTHIER E
DURANDZALESKI I
CARLSON R
RUSTUM Y
ERLICHMAN C
Citation: N. Wolmark et al., EFFICACY OF INTRAVENOUS CONTINUOUS-INFUSION OF FLUOROURACIL COMPARED WITH BOLUS ADMINISTRATION IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 301-308
Authors:
LOKICH J
LEVINE H
NASSER I
Citation: J. Lokich et al., MALIGNANCY-RELATED HYDROCEPHALUS - CLINICAL-FEATURES AND RESULTS OF VENTRICULAR PERITONEAL SHUNT PROCEDURE IN 3 PATIENTS, American journal of clinical oncology, 21(4), 1998, pp. 366-368
Authors:
LOKICH J
Citation: J. Lokich, CARCINOID-TUMOR REGRESSION WITH HIGH-DOSE OCTREOTIDE ACETATE - A PATIENT REPORT, American journal of clinical oncology, 21(3), 1998, pp. 246-247
Authors:
LOKICH J
ANDERSON N
Citation: J. Lokich et N. Anderson, DOSE INTENSITY FOR BOLUS VERSUS INFUSION CHEMOTHERAPY ADMINISTRATION - REVIEW OF THE LITERATURE FOR 27 ANTINEOPLASTIC AGENTS, Annals of oncology, 8(1), 1997, pp. 15-25
Authors:
LOKICH J
Citation: J. Lokich, SPONTANEOUS REGRESSION OF METASTATIC RENAL-CANCER - CASE-REPORT AND LITERATURE-REVIEW, American journal of clinical oncology, 20(4), 1997, pp. 416-418
Authors:
LOKICH J
Citation: J. Lokich, INDIVIDUAL CHOICE AND MEDICAL LOGIC AT ODDS - WHO SHOULD DETERMINE THE LEVEL OF AGGRESSIVENESS IN CASES OF ADVANCED, INCURABLE CANCER - RESPONSE, Seminars in oncology, 23(5), 1996, pp. 23-24
Authors:
LOKICH J
Citation: J. Lokich, CLINICAL PROBLEM-SOLVING - HYPEREOSINOPHILIC SYNDROME, The New England journal of medicine, 334(8), 1996, pp. 538-538
Authors:
LOKICH J
ANDERSON N
BERN M
COCO F
DOW E
MOORE C
ZIPOLI T
GONZALVES L
Citation: J. Lokich et al., MULTI-DAY FRACTIONATED ADMINISTRATION SCHEDULE FOR PACLITAXEL, Annals of oncology, 6(9), 1995, pp. 883-885
Authors:
LOKICH J
ANDERSON N
Citation: J. Lokich et N. Anderson, INFUSIONAL CANCER-CHEMOTHERAPY - HISTORICAL EVOLUTION AND FUTURE-DEVELOPMENT AT THE CANCER-CENTER-OF-BOSTON, Cancer investigation, 13(2), 1995, pp. 202-226
Authors:
LOKICH J
Citation: J. Lokich, ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN THERAPY FOR REFRACTORY CHILDHOODSOLID TUMORS, Cancer, 76(9), 1995, pp. 1686-1686
Authors:
LOKICH J
Citation: J. Lokich, METACHRONOUS GONADAL AND EXTRAGONADAL PRIMARY GERM-CELL TUMORS - 2 CASE-REPORTS, Cancer investigation, 12(4), 1994, pp. 406-408
Authors:
LOKICH J
Citation: J. Lokich, METASTATIC ADAMANTINOMA OF BONE TO LUNG - A CASE-REPORT OF THE NATURAL-HISTORY AND THE USE OF CHEMOTHERAPY AND RADIATION-THERAPY, American journal of clinical oncology, 17(2), 1994, pp. 157-159
Authors:
LOKICH J
Citation: J. Lokich, A PHASE-II STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN ADVANCED HORMONE-REFRACTORY PROSTATE-CANCER - AN ILLINOIS CANCER CENTER STUDY, Cancer, 73(5), 1994, pp. 1536-1537
Risultati:
1-25
|